Log In
Print
BCIQ
Print
Print this Print this
 

PP-001

  Manage Alerts
Collapse Summary General Information
Company 4SC AG
DescriptionSmall molecule inhibitor of interferon (IFN) gamma and interleukin-17 (IL-17)
Molecular Target Interferon (IFN) gamma ; Interleukin-17 (IL-17)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationUveitis
Indication DetailsTreat chronic uveitis
Regulatory Designation

Partner

Panoptes Pharma GmbH


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today